BUDESONIDE IS SUPERIOR TO MESALAZINE AND PLACEBO FOR INDUCTION OF REMISSION IN LYMPHOCYTIC COLITIS

(1) Center for Digestive Diseases,Cooperation of Internal Medicine,Hamburg,Germany

(2) Institute of Pathology, University Hospital,Dresden,Germany

(3) Semmelweis Egyetem,Budapest,Hungary

(4) Practice for Gastroenterology,Berlin,Germany

(5) Internist practice,Ludwigshafen,Germany

(6) Regional Hospital Silkeborg,Department of Gastroenterology,Silkeborg,Denmark

(7) Hospital Mutua de Tarrassa,Barcelona,Spain

(8) Hospital of Lithuanian University of Health Sciences Kaunas Clinics,Kaunas,Lithuania

(9) Køge Hospital Dept. of Medicine,Internal Medicine,Køge,Denmark

(10) Community Practice Gastroenterology,Solingen,Germany

(11) Dr. Falk Pharma GmbH,Freiburg,Germany

(12) R&D Dr. Falk Pharma GmbH,Forschung und Entwicklung,Freiburg,Germany

(13) Linköping University,Linköping,Sweden



This item was part of UEG Week 2017

This item can be cited as: United European Gastroenterology Journal 2017; 5 (Supplement 1)